Tag: Research Recognition Award

Sayan Chakraborty | Molecular Biology | Best Researcher Award

Published on by World Science Awards

Assist. Prof. Dr. Sayan Chakraborty | Molecular Biology | Best Researcher Award

Assistant Professor of Oncology from Roswell Park Comprehensive Cancer Center, United States

Dr. Sayan Chakraborty is an Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center, specializing in cancer biology and regenerative medicine. His research focuses on the role of extracellular matrix (ECM) proteins in cancer progression, particularly in liver cancer. With a strong background in microbiology, immunology, and cancer research, he has made significant contributions to understanding tumor microenvironments. Dr. Chakraborty has published extensively in high-impact journals, secured multiple research grants, and holds patents related to cancer diagnostics and therapies. He actively mentors Ph.D. students and postdoctoral researchers while serving on editorial boards of prestigious scientific journals. His work has been recognized through several national and international awards, including the A*STAR Career Development Award and Open Fund Young Investigator Grant. As an invited speaker at international conferences, he continues to shape the field of cancer research through his pioneering work in mechanotransduction and ECM-targeted therapies.

Professional Profile

Education

Dr. Chakraborty completed his Bachelor of Science (B.Sc.) in Zoology with honors from Presidency College, University of Calcutta, in 2006. He then pursued a Master of Science (M.Sc.) in Biochemistry at the University of Calcutta, graduating in 2008. His doctoral studies focused on the entry mechanisms of oncogenic human herpesvirus-8 (HHV-8/KSHV) and their role in Kaposi’s sarcoma development. He earned his Ph.D. from Rosalind Franklin University of Medicine and Sciences, USA, in collaboration with the Institute of Molecular and Cell Biology, Singapore. His postdoctoral training further refined his expertise in microbiology, immunology, and cancer research. With extensive training across renowned institutions in India, the USA, and Singapore, Dr. Chakraborty has built a strong foundation in cancer biology, extracellular matrix research, and mechanotransduction pathways in tumor progression.

Professional Experience

Dr. Chakraborty has held various research and academic positions across multiple prestigious institutions. He began his career as a Research Fellow at the Institute of Molecular and Cell Biology (IMCB), Singapore, in 2012. He was later promoted to Senior Research Fellow and then Research Assistant Professor at the same institute, focusing on cancer research and extracellular matrix dynamics. In 2022, he joined Roswell Park Comprehensive Cancer Center as an Assistant Professor of Oncology, where he is also a member of the Developmental Therapeutics Research Program. Additionally, he plays an active role in graduate education and experimental therapeutics programs. His research contributions extend beyond academia, as he serves as an editorial board member and peer reviewer for high-impact journals. His work in ECM-targeted cancer therapies and mechanotransduction has led to international recognition, positioning him as a key figure in oncology research.

Research Interests

Dr. Chakraborty’s research focuses on the role of extracellular matrix proteins in cancer progression and regenerative medicine. His laboratory investigates how tumor cells interact with ECM components, leading to changes in mechanotransduction pathways that drive oncogenic signaling. A major aspect of his work revolves around Agrin, a key ECM protein that promotes cancer progression through YAP/TAZ signaling and integrin-mediated mechanosensing. His studies explore how ECM-targeted strategies can disrupt tumor growth and angiogenesis, offering new therapeutic approaches for hepatocellular carcinoma and other cancers. Additionally, he is interested in the intersection of ECM biology and tissue regeneration, aiming to develop novel biomaterials for wound healing applications. His long-term research goal is to devise tumor-restraining strategies by targeting ECM components and their interactions with cancer cells, leading to more effective treatment options for patients.

Research Skills

Dr. Chakraborty has expertise in multiple advanced research methodologies, including molecular and cellular biology, cancer signaling, and mechanotransduction analysis. His laboratory specializes in ECM protein characterization, cancer cell migration assays, and 3D tumor modeling. He is proficient in high-resolution imaging techniques, such as confocal and electron microscopy, to analyze ECM-cancer interactions. Additionally, his skills in RNA sequencing, proteomics, and CRISPR-based gene editing allow for comprehensive molecular investigations in oncology. He has experience in preclinical cancer models, including xenograft and organoid systems, to study tumor microenvironments and evaluate potential therapeutics. His ability to integrate mechanobiology with cancer research has led to groundbreaking discoveries in ECM-targeted therapies. Beyond experimental techniques, he is skilled in grant writing, scientific publishing, and mentoring researchers, further contributing to the advancement of oncology research.

Awards and Honors

Dr. Chakraborty has received numerous accolades for his contributions to cancer research. He was awarded the Aparajita Memorial Gold Medallion for securing the first rank in his B.Sc. studies at Presidency College. He also received the CSIR-UGC Merit Scholarship and the University of Calcutta Foreign Scholarship for academic excellence. His doctoral work earned him the Dean’s Award for Outstanding Achievement in Research from Rosalind Franklin University. In Singapore, he was honored with the Early Career Research Award and the Open Fund Young Investigator Research Grant. His A*STAR Career Development Award recognized his pioneering work in ECM-targeted therapies. Recently, he secured the Cancer Center Support Grant at Roswell Park, further advancing his research into ECM and cancer therapeutics. These awards highlight his consistent excellence in research, funding acquisition, and scientific innovation.

Conclusion

Dr. Sayan Chakraborty is a leading researcher in cancer biology, with extensive contributions to understanding the extracellular matrix’s role in tumor progression. His research has led to the identification of ECM-targeted therapeutic strategies, with a particular focus on liver cancer. With a strong academic background, multiple international research experiences, and significant funding successes, he has established himself as a distinguished scientist in oncology. His mentorship, editorial roles, and extensive publication record further reflect his dedication to advancing cancer research. While his work is already making an impact, expanding clinical collaborations and large-scale translational studies could enhance the real-world applications of his findings. Dr. Chakraborty’s pioneering research, coupled with his leadership in the field, makes him a strong candidate for prestigious research awards and continued recognition in cancer biology.

Publications Top Notes

  1. Title: Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway
    Authors: S. Chakraborty, K. Njah, A. Pobbati, Y.B. Lim, A. Raju, M. Lakshmanan, …
    Year: 2017
    Citations: 225

  2. Title: Kaposi’s sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes
    Authors: V.V. Singh, N. Kerur, V. Bottero, S. Dutta, S. Chakraborty, M.A. Ansari, …
    Year: 2013
    Citations: 175

  3. Title: An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma
    Authors: S. Chakraborty, M. Lakshmanan, H.L.F. Swa, J. Chen, X. Zhang, Y.S. Ong, …
    Year: 2015
    Citations: 155

  4. Title: Kaposi’s sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection
    Authors: S. Chakraborty, M.V. Veettil, V. Bottero, B. Chandran
    Year: 2012
    Citations: 125

  5. Title: Kaposi’s sarcoma associated herpesvirus entry into target cells
    Authors: S. Chakraborty, M. Valiya Veettil, B. Chandran
    Year: 2012
    Citations: 110

  6. Title: Interaction of c-Cbl with Myosin IIA Regulates Bleb Associated Macropinocytosis of Kaposi’s Sarcoma-Associated Herpesvirus
    Authors: M.V. Veettil, S. Sadagopan, N. Kerur, S. Chakraborty, B. Chandran
    Year: 2010
    Citations: 82

  7. Title: Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival
    Authors: S. Sadagopan, M.V. Veettil, S. Chakraborty, N. Sharma-Walia, N. Paudel, …
    Year: 2012
    Citations: 73

  8. Title: Reactive oxygen species are induced by Kaposi’s sarcoma-associated herpesvirus early during primary infection of endothelial cells to promote virus entry
    Authors: V. Bottero, S. Chakraborty, B. Chandran
    Year: 2013
    Citations: 65

  9. Title: EphrinA2 regulates clathrin mediated KSHV endocytosis in fibroblast cells by coordinating integrin-associated signaling and c-Cbl directed polyubiquitination
    Authors: D. Dutta, S. Chakraborty, C. Bandyopadhyay, M. Valiya Veettil, M.A. Ansari, …
    Year: 2013
    Citations: 63

  10. Title: Linking extracellular matrix agrin to the hippo pathway in liver cancer and beyond
    Authors: S. Chakraborty, W. Hong
    Year: 2018
    Citations: 60

  11. Title: c-Cbl-Mediated Selective Virus-Receptor Translocations into Lipid Rafts Regulate Productive Kaposi’s Sarcoma-Associated Herpesvirus Infection in Endothelial Cells
    Authors: S. Chakraborty, M. Valiya Veettil, S. Sadagopan, N. Paudel, B. Chandran
    Year: 2011
    Citations: 54

  12. Title: The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability
    Authors: A.M. Roy, R. Iyer, S. Chakraborty
    Year: 2023
    Citations: 47

Cheng Hu | Materials Science | Excellence in Innovation

Published on by World Science Awards

Assoc Prof Dr. Cheng Hu | Materials Science | Excellence in Innovation

Associate Professor at Sichuan University, China.

Cheng Hu is an accomplished Associate Professor at Sichuan University, specializing in biomaterials and biomedical engineering. With a profound focus on developing innovative microenvironment-responsive delivery systems, Hu’s research addresses critical biomedical challenges such as myocardial infarction and stroke. His work emphasizes the integration of smart biomaterials, hydrogels, and organic synthesis within the realm of materials chemistry. An active contributor to the academic community, Hu has a robust publication record, including numerous articles in high-impact journals, showcasing his commitment to advancing scientific knowledge and improving patient outcomes. His collaborative efforts extend across multiple disciplines, enhancing the translational potential of his research. Hu is recognized for his editorial contributions to various journals, demonstrating his dedication to fostering innovation in the field of biomedical engineering. Through his innovative approach, he aims to bridge the gap between research and clinical applications, ultimately improving healthcare delivery and patient care.

Professional Profile

Education

Cheng Hu earned his Ph.D. in Biomedical Engineering, where he focused on the synthesis and characterization of novel biomaterials for medical applications. His educational journey laid a solid foundation in materials chemistry, enabling him to explore complex interactions between biomaterials and biological systems. During his doctoral studies, he honed his skills in hydrogel development and drug delivery mechanisms, paving the way for his future research endeavors. Following his Ph.D., Hu continued to expand his expertise through postdoctoral research positions, where he collaborated with leading experts in the field. This experience enriched his knowledge of smart materials and their applications in regenerative medicine. Hu’s comprehensive educational background equips him with the theoretical understanding and practical skills necessary to tackle pressing challenges in biomedical engineering, making him a valuable contributor to the academic and scientific communities.

Professional Experience

Cheng Hu currently serves as an Associate Professor at the National Engineering Research Center for Biomaterials at Sichuan University, where he has been since July 2021. In this role, he leads various research projects focusing on smart biomaterials and drug delivery systems. Prior to this position, Hu gained significant experience in both academic and industrial settings, contributing to multidisciplinary teams that aimed to develop innovative solutions for biomedical challenges. His work involves extensive collaboration with clinicians and researchers, facilitating the translation of research findings into practical applications. Hu has also participated in numerous international conferences, presenting his findings and engaging with peers in the field. His professional experience has established him as a respected figure in biomedical engineering, known for his dedication to research excellence and innovation. Through his leadership and mentorship, Hu inspires the next generation of scientists while advancing the field of biomaterials.

Research Interests

Cheng Hu’s primary research interests lie in the development of microenvironment-responsive delivery systems, with a strong emphasis on smart biomaterials and their biomedical applications. His work focuses on innovative approaches to drug delivery, particularly through the use of hydrogels that respond to physiological stimuli. This includes exploring their potential in treating conditions such as myocardial infarction and stroke. Additionally, Hu is passionate about the construction of multifunctional hydrogels that integrate anti-inflammatory and pro-angiogenic properties for enhanced tissue regeneration. His research extends to the field of cardiovascular diseases, where he aims to create materials that improve patient outcomes through targeted therapies. By investigating the interplay between materials chemistry and biomedical engineering, Hu seeks to bridge the gap between basic research and clinical applications, ultimately contributing to the advancement of regenerative medicine.

Research Skills

Cheng Hu possesses a diverse array of research skills that underpin his contributions to biomaterials and biomedical engineering. His expertise encompasses the synthesis and characterization of novel hydrogels and biomaterials, employing techniques such as organic synthesis, materials chemistry, and polymer science. Hu is proficient in developing and optimizing drug delivery systems that respond to specific physiological triggers, enhancing therapeutic efficacy. Additionally, he has strong analytical skills, enabling him to conduct in-depth evaluations of material properties and their interactions with biological systems. His proficiency in various characterization techniques, including spectroscopy and microscopy, further strengthens his research capabilities. Hu is also experienced in collaborating with interdisciplinary teams, fostering communication and innovation in project development. His commitment to rigorous scientific methodology and continuous learning enables him to stay at the forefront of advancements in biomaterials and biomedical research.

Awards and Honors

Cheng Hu has received numerous accolades for his contributions to the field of biomedical engineering, recognizing his innovative research and commitment to excellence. His work has been published in high-impact journals, garnering citations and praise from peers worldwide. Hu has been invited to present his research at prestigious international conferences, showcasing his role as a leader in the field. His editorial involvement with various academic journals highlights his recognition as an expert in biomaterials, further solidifying his reputation within the scientific community. Additionally, he has been acknowledged for his collaborative efforts, receiving funding for several research projects aimed at advancing smart biomaterials for medical applications. These awards and honors reflect Hu’s dedication to pushing the boundaries of biomedical engineering and his ongoing contributions to improving patient care through innovative research.

Conclusion:

Cheng Hu is a commendable candidate for the Excellence in Innovation award, demonstrating a strong foundation in biomedical research with notable contributions to smart biomaterials. His innovative approaches to drug delivery and tissue engineering are poised to make significant impacts in clinical applications. By addressing the suggested areas for improvement, he could further enhance his influence and leadership in the field, ensuring that his research translates into meaningful innovations for patient care.

Publications Top Notes

  1. Eco-toxicological effects assessment: comparative characteristics of environmental conditions and Dynamically crosslinked ECM-like hydrogels loaded with ROS-responsive drug nanoparticles for treating inflammation in myocardial infarction and stroke
    • Authors: Wang, Z., Hu, C., Zhang, W., Yang, L., Wang, Y.
    • Year: 2024
  2. Effects of flavor components of sauce-flavor Baijiu on ethanol metabolism and key enzyme activities in mice | 酱香型白酒风味成分对小鼠乙醇代谢及关键酶活性的影响
    • Authors: Han, R., Fang, S., Xia, Y., Zhao, Y., Hu, C.
    • Year: 2024
  3. Remodeling brain pathological microenvironment to lessen cerebral ischemia injury by multifunctional injectable hydrogels
    • Authors: Zhang, W., Liu, Y., Wang, Z., Hu, C., Wang, Y.
    • Year: 2024
  4. Progress of Research on Conductive Hydrogels in Flexible Wearable Sensors
    • Authors: Cao, J., Wu, B., Yuan, P., Liu, Y., Hu, C.
    • Year: 2024
  5. A Whole-Course-Repair System Based on Stimulus-Responsive Multifunctional Hydrogels for Myocardial Tissue Regeneration
    • Authors: Liu, W., Long, L., Wang, Z., Hu, C., Wang, Y.
    • Year: 2024
  6. An injectable carrier for spatiotemporal and sequential release of therapeutic substances to treat myocardial infarction
    • Authors: Liu, W., Hu, C., Long, L., Yang, L., Wang, Y.
    • Year: 2024
  7. A Versatile Glycopeptide Hydrogel Promotes Chronic Refractory Wound Healing Through Bacterial Elimination, Sustained Oxygenation, Immunoregulation, and Neovascularization
    • Authors: Wu, Y., Wang, Y., Zheng, C., Zhang, H., Wang, Y.
    • Year: 2023
  8. Rational Design of Multifunctional Hydrogels for Wound Repair
    • Authors: Cao, J., Wu, B., Yuan, P., Liu, Y., Hu, C.
    • Year: 2023
  9. Polyphenol-mediated sandwich-like coating promotes endothelialization and vascular healing
    • Authors: Wan, H., Li, Y., Qin, Y., Zhang, B., Wang, Y.
    • Year: 2023
  10. Combining HUMSC secretome and a conductive hydrogel enhances angiogenesis and electrical transmission at myocardial infarct sites to support cardiac repair
    • Authors: He, S.-Y., Long, L.-Y., Wang, Z.-C., Li-Yang, Wang, Y.-B.
    • Year: 2023